DoJ OKs CVS, Aetna merger with conditions

Oct 11, 2018

The Department of Justice will allow the $69 billion CVS-Aetna deal to proceed if the sale to WellCare is completed.

The Department of Justice said it is requiring CVS and Aetna to divest Aetna’s Medicare Part D prescription drug plan business for individuals in order to proceed with their merger. The sale will appease the DOJ’s concerns of anticompetitive effects due to CVS already having its own Medicare Part D prescription drug plans under the “SilverScript” brand.

CVS runs the country’s largest retail pharmacy chain and provides prescription plans to more than 94 million customers. Joining forces with the nation’s third-largest health-insurance provider will solidify CVS’s grip on the market.

Read the DOJ press release

Want to get news like this in your inbox?  Subscribe to our eNewsletter here!

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments